Cargando…

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply

Detalles Bibliográficos
Autores principales: Kashour, Tarek, Tleyjeh, Imad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938745/
https://www.ncbi.nlm.nih.gov/pubmed/33705848
http://dx.doi.org/10.1016/j.cmi.2021.02.024
_version_ 1783661646950957056
author Kashour, Tarek
Tleyjeh, Imad M.
author_facet Kashour, Tarek
Tleyjeh, Imad M.
author_sort Kashour, Tarek
collection PubMed
description
format Online
Article
Text
id pubmed-7938745
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-79387452021-03-09 Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply Kashour, Tarek Tleyjeh, Imad M. Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021-08 2021-03-08 /pmc/articles/PMC7938745/ /pubmed/33705848 http://dx.doi.org/10.1016/j.cmi.2021.02.024 Text en © 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Kashour, Tarek
Tleyjeh, Imad M.
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
title Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
title_full Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
title_fullStr Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
title_full_unstemmed Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
title_short Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
title_sort efficacy and safety of tocilizumab in covid-19 patients: a living systematic review and meta-analysis – author’s reply
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938745/
https://www.ncbi.nlm.nih.gov/pubmed/33705848
http://dx.doi.org/10.1016/j.cmi.2021.02.024
work_keys_str_mv AT kashourtarek efficacyandsafetyoftocilizumabincovid19patientsalivingsystematicreviewandmetaanalysisauthorsreply
AT tleyjehimadm efficacyandsafetyoftocilizumabincovid19patientsalivingsystematicreviewandmetaanalysisauthorsreply